A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis

BackgroundMultiple Sclerosis (MS) is a multi-factorial disease, where a single biomarker unlikely can provide comprehensive information. Moreover, due to the non-linearity of biomarkers, traditional statistic is both unsuitable and underpowered to dissect their relationship. Patients affected with primary (PP=14), secondary (SP=33), benign (BB=26), relapsing-remitting (RR=30) MS, and 42 sex and age matched healthy controls were studied. We performed a depth immune-phenotypic and functional analysis of peripheral blood mononuclear cell (PBMCs) by flow-cytometry. Semantic connectivity maps (AutoCM) were applied to find the natural associations among immunological markers. AutoCM is a special kind of Artificial Neural Network able to find consistent trends and associations among variables. The matrix of connections, visualized through minimum spanning tree, keeps non linear associations among variables and captures connection schemes among clusters.ResultsComplex immunological relationships were shown to be related to different disease courses. Low CD4IL25+ cells level was strongly related (link strength, ls=0.81) to SP MS. This phenotype was also associated to high CD4ROR+ cells levels (ls=0.56). BB MS was related to high CD4+IL13 cell levels (ls=0.90), as well as to high CD14+IL6 cells percentage (ls=0.80). RR MS was strongly (ls=0.87) related to CD4+IL25 high cell levels, as well indirectly to high percentages of CD4+IL13 cells. In this latter strong (ls=0.92) association could be confirmed the induction activity of the former cells (CD4+IL25) on the latter (CD4+IL13). Another interesting topographic data was the isolation of Th9 cells (CD4IL9) from the main part of the immunological network related to MS, suggesting a possible secondary role of this new described cell phenotype in MS disease.ConclusionsThis novel application of non-linear mathematical techniques suggests peculiar immunological signatures for different MS phenotypes. Notably, the immune-network displayed by this new method, rather than a single marker, might be viewed as the right target of immunotherapy. Furthermore, this new statistical technique could be also employed to increase the knowledge of other age-related multifactorial disease in which complex immunological networks play a substantial role.

[1]  H. Hartung,et al.  Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis , 2005, The Lancet Neurology.

[2]  C. Caruso Immunity & Ageing , 2009 .

[3]  M. Filippi,et al.  Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease , 2001, Journal of Neuroimmunology.

[4]  Paolo Massimo Buscema,et al.  The semantic connectivity map: an adapting self-organising knowledge discovery method in data bases. Experience in gastro-oesophageal reflux disease , 2008, Int. J. Data Min. Bioinform..

[5]  M. Clerici,et al.  Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis. , 1998, Journal of immunology.

[6]  M. Rovaris,et al.  Immunological patterns identifying disease course and evolution in multiple sclerosis patients , 2005, Journal of Neuroimmunology.

[7]  Paolo Massimo Buscema,et al.  The IFAST model, a novel parallel nonlinear EEG analysis technique, distinguishes mild cognitive impairment and Alzheimer's disease patients with high degree of accuracy , 2007, Artif. Intell. Medicine.

[8]  V. Kuchroo,et al.  IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cells , 2008, Nature Immunology.

[9]  T. Mcclanahan,et al.  Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract , 2006, The Journal of experimental medicine.

[10]  A. Thompson,et al.  Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.

[11]  David C. Snowdon,et al.  Auto-Contractive Maps: an artificial adaptive system for data mining. An application to Alzheimer disease. , 2008, Current Alzheimer research.

[12]  M Rovaris,et al.  MRI features of benign multiple sclerosis , 2009, Neurology.

[13]  D. J. Matthews,et al.  IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. , 2000, Immunity.

[14]  B. Becher,et al.  IL-9 as a mediator of Th17-driven inflammatory disease , 2009, The Journal of experimental medicine.

[15]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[16]  B. Castellano,et al.  Increase in Th17 and T-reg Lymphocytes and Decrease of IL22 Correlate with the Recovery Phase of Acute EAE IN Rat , 2011, PloS one.

[17]  M. Clerici,et al.  CD4+CD25+FoxP3+PD1— regulatory T cells in acute and stable relapsing‐remitting multiple sclerosis and their modulation by therapy , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  T. Wynn,et al.  Regulation and Function of the Interleukin 13 Receptor α 2 During a T Helper Cell Type 2–dominant Immune Response , 2003, The Journal of experimental medicine.

[19]  A. Thompson,et al.  Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis , 2004, Multiple sclerosis.

[20]  B. Becher,et al.  Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis , 2005, Nature Medicine.

[21]  F. Paul,et al.  Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica , 2007, PLoS medicine.

[22]  M. Buscema Auto-Contractive Maps, H Function and Maximally Regular Graph - Theory , 2009 .

[23]  M. Leach,et al.  IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. , 2001, Immunity.